权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Development of Spectral Phase Contrast Micro-CT

光谱相差显微CT的研制

基本信息

批准号：
10388152
负责人：
Mini Das
金额：
$ 62.08万
依托单位：
UNIVERSITY OF HOUSTON
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-07-01 至 2026-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10388152
关键词：
3-Dimensional Address Algorithms Animal Experiments Animal Model Animals Area Blood Blood Vessels Calibration Clinical Collaborations Contrast Media Contrast Sensitivity Coupled Czech Republic Data Detection Development Discrimination Dose Geometry Grant Image Image Enhancement Iodine Licensing Liposomes Longitudinal Studies Malignant Neoplasms Maps Masks Measurement Measures Methods Mus Performance Phase Preclinical Drug Development Process Property Qualifying Radiation Dose Unit Research Personnel Resolution Retrieval Roentgen Rays Scheme Signal Transduction Source Structure System Task Performances Technology Testing Thick Time Tissue imaging Tissues Tube Universities Variant Vendor Work absorption animal imaging anticancer research attenuation contrast enhanced contrast imaging cost design detector electron density experimental study imaging capabilities imaging modality imaging study improved in vivo in vivo imaging industry partner innovation microCT nanoparticle next generation novel parametric imaging phase change photon-counting detector prostate cancer model public health relevance sensor simulation soft tissue tomography transmission process tumor

项目摘要

Development of Spectral X-Ray Phase-Contrast Micro-CT Project Summary A challenging aspect of in vivo micro-CT relates to the required deleterious radiation dose levels - particularly for studies required to follow the same subject longitudinally. The main constraint is the poor attenuation contrast for x-rays in soft tissue and the need for long imaging times. Researchers have studied the use of multi-energy (or spectral) x-ray acquisitions to perform material decomposition with micro-CT systems, but the versatility of these methods is again constrained by the same contrast-dose trade-off. Phase-contrast imaging (PCI) can provide significant phase-enhanced contrast at higher energies, thus potentially reducing micro-CT dose. However, existing PCI methods still require high dose and long imaging times for accurate phase retrieval. We have recently developed an algorithmic approach to spectral PCI that enables dose and imaging times commensurate with attenuation imaging. Our hypothesis is that PCI performed under normal clinical constraints can yield better tissue quantitation and small feature delineation at lower dose than attenuation imaging. We shall develop a unique spectral micro-CT system with both PCI and non-PCI capabilities to test this hypothesis. A key system component will be an innovative high-performance, high-resolution photon- counting detector (PCD) to be developed jointly under this grant by the University of Houston and Advacam s.r.o. Two non-interferometric PCI geometries will be evaluated. The first specific aim is to design the micro- CT system based on considerations such as source kVp and the PCD sensor thickness, pixel size, and energy bin configuration. PCI-specific criteria include magnification and the x-ray mask properties. Optimization studies will be carried out for both the PCI and the non-PCI modes. For Aim 2, we will work with Advacam to develop the wide-area, high frame rate and high Z sensor PCD for the system. The high-performance PCD will be constructed based on Medipix3RX ASIC technology and will feature high resolution and built-in spectral correction schemes and fast readouts. Under Aim 3, the micro-CT unit will be constructed and energy calibration and correction schemes will be developed to allow efficient system performance. Our fourth specific aim is to compare the performance of the PCI and non-PCI modes of spectral micro-CT with physical phantoms and animal studies to evaluate the enhancement of low contrast sensitivity. In vivo studies using liposomal iodine nanoparticles will examine the ability of PCI to distinguish differences in blood vascularity for treatment- responsive and treatment-resistive prostate cancer models in mice.

x射线相衬显微ct的发展